29th Nov 2022 2:06 pm |
RNS |
Second Price Monitoring Extn |
29th Nov 2022 2:00 pm |
RNS |
Price Monitoring Extension |
16th Nov 2022 7:00 am |
RNS |
AGM Notification |
11th Nov 2022 7:00 am |
RNS |
Financial Results for the First Quarter |
8th Nov 2022 7:00 am |
RNS |
Results for the 12-month period ended 30 June 2022 |
28th Oct 2022 7:00 am |
RNS |
Notification of Preliminary Results and AGM |
28th Apr 2022 7:00 am |
RNS |
Q3 Financial Results |
1st Apr 2022 7:00 am |
RNS |
Sanofi Bangladesh Ltd. renamed Synovia Pharma PLC |
17th Mar 2022 2:30 pm |
RNS |
MPP sub-license for Pfizer’s COVID-19 treatment |
28th Jan 2022 7:00 am |
RNS |
Half Year Results 2021-22 |
21st Jan 2022 7:00 am |
RNS |
Payment of Cash Dividend |
20th Jan 2022 9:00 am |
RNS |
License to produce molnupiravir for COVID-19 |
30th Dec 2021 10:38 am |
RNS |
World's first generic version of Pfizer’s Paxlovid |
24th Dec 2021 7:00 am |
RNS |
Annual General Meeting Statement |
8th Dec 2021 7:00 am |
RNS |
Delivery of COVID-19 vaccine doses |
2nd Dec 2021 7:00 am |
RNS |
Update on the supply of COVID-19 vaccine |
24th Nov 2021 7:43 am |
RNS |
Statement re: media comment |
16th Nov 2021 7:00 am |
RNS |
Notice of AGM |
11th Nov 2021 10:30 am |
RNS |
Results for First Quarter Ended 30 September 2021 |
9th Nov 2021 7:00 am |
RNS |
Launch of world’s first generic molnupiravir |
2nd Nov 2021 7:00 am |
RNS |
Results for the year ended 30 June 2021 |
21st Oct 2021 12:36 pm |
RNS |
Notification of Preliminary Results and AGM |
11th Oct 2021 7:00 am |
RNS |
Update on the supply of COVID-19 vaccine |
1st Oct 2021 7:00 am |
RNS |
Completion of Sanofi Bangladesh Acquisition |
14th Sep 2021 10:20 am |
RNS |
Sanofi Bangladesh Share Purchase Agreement signed |
3rd Sep 2021 1:10 pm |
RNS |
Acquisition Approved by Bangladesh Bank |
25th Aug 2021 6:01 pm |
RNS |
Statement re: media comment |
26th Jul 2021 7:00 am |
RNS |
FDA approval for muscle relaxant drug Baclofen |
7th Jul 2021 2:23 pm |
RNS |
Update on the supply of COVID-19 vaccine |
30th Apr 2021 7:00 am |
RNS |
Q3 Financial Results |
28th Apr 2021 7:00 am |
RNS |
Update on the supply of COVID-19 vaccine |
24th Mar 2021 4:41 pm |
RNS |
Second Price Monitoring Extn |
24th Mar 2021 4:36 pm |
RNS |
Price Monitoring Extension |
24th Mar 2021 2:06 pm |
RNS |
Second Price Monitoring Extn |
24th Mar 2021 2:00 pm |
RNS |
Price Monitoring Extension |
24th Mar 2021 11:06 am |
RNS |
Second Price Monitoring Extn |
24th Mar 2021 11:00 am |
RNS |
Price Monitoring Extension |
4th Feb 2021 7:34 am |
RNS |
Update on the supply of COVID-19 vaccine |
28th Jan 2021 7:00 am |
RNS |
Half Year Results 2020-21 |
22nd Jan 2021 7:00 am |
RNS |
Payment of Cash Dividend |